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Outline
• Problem: reliable differential quantitation
• Solution: peptide-based models
• Improving solution via:
1. Shrinkage estimation
2. Borrowing information across proteins
3. Weighing down outliers
• Leads to:
1. Better fold change estimates
2. Better sensitivity and specificity
• Conclusions: all of the above
• Acknowledgements
For each protein:
Problem: how to do differential quantification?
22.6464 Treatment 1 Peptide A Rep 1
17.85773 Treatment 1 Peptide B Rep 1
15.4947 Treatment 1 Peptide C Rep 2
14.02125 Treatment 1 Peptide D Rep 2
18.0965 Treatment 2 Peptide A Rep 3
14.59100 Treatment 2 Peptide B Rep 3
14.2959 Treatment 2 Peptide C Rep 3
𝑡𝑟𝑒𝑎𝑡𝑚𝑒𝑛𝑡 + 𝑝𝑒𝑝𝑡𝑖𝑑𝑒 + 𝑟𝑒𝑝𝑒𝑎𝑡log2 𝑀𝑆 𝑖𝑛𝑡𝑒𝑛𝑠𝑖𝑡𝑦
Solution: 2 main ways:
Problem: how to do differential quantification?
Normalisation
Normalisation
+summarization
(e.g. MaxLFQ)
T-tests
(e.g. 
Perseus)
Peptide
intensities
Peptide-
based
models
1. Summarize
to protein
level
2. Peptide-
based models
Peptide-based models are superior
Daly, et al. (2008), Journal of Proteome Research, 7, (3), 1209-1217.
Clough et al. (2009, Journal of Proteome Research, 8, (11), 5275-5284.
Karpievitch et al. (2009), Bioinformatics, 25, (16), 2028-2034.
Goeminne et al. (2015), Journal of Proteome Research , 14, (6), 2457-2465.
Spike-in: 48 human proteins 
in yeast proteome
A model for each protein:
Peptide-based models
22.6464 Intercept Treatment 1 Peptide A Rep 1 Error 1
17.85773 Intercept Treatment 1 Peptide B Rep 1 Error 2
15.4947 Intercept Treatment 1 Peptide C Rep 2 Error 3
14.02125 Intercept Treatment 1 Peptide D Rep 2 Error 4
18.0965 Intercept Treatment 2 Peptide A Rep 3 Error 5
14.59100 Intercept Treatment 2 Peptide B Rep 3 Error 6
14.2959 Intercept Treatment 2 Peptide C Rep 3 Error 7
log2 𝑀𝑆 𝑖𝑛𝑡𝑒𝑛𝑠𝑖𝑡𝑦 ~ 𝑖𝑛𝑡𝑒𝑟𝑐𝑒𝑝𝑡 + 𝑡𝑟𝑒𝑎𝑡𝑚𝑒𝑛𝑡 + 𝑝𝑒𝑝𝑡𝑖𝑑𝑒 + 𝑟𝑒𝑝𝑒𝑎𝑡 + 𝑒𝑟𝑟𝑜𝑟
A model for each protein:
Peptide-based models
22.6464 16 1.5 4.5 0.5 0.1464
17.85773 16 1.5 -0.2 0.5 0.05773
15.4947 16 1.5 -1 -0.7 -0.3053
14.02125 16 1.5 -2 -0.7 -0.77875
18.0965 16 -1.5 4.5 -0.3 -0.6035
14.59100 16 -1.5 -0.2 -0.3 0.59100
14.2959 16 -1.5 -1 -0.3 0.0959
log2 𝑀𝑆 𝑖𝑛𝑡𝑒𝑛𝑠𝑖𝑡𝑦 ~ 𝑖𝑛𝑡𝑒𝑟𝑐𝑒𝑝𝑡 + 𝑡𝑟𝑒𝑎𝑡𝑚𝑒𝑛𝑡 + 𝑝𝑒𝑝𝑡𝑖𝑑𝑒 + 𝑟𝑒𝑝𝑒𝑎𝑡 + 𝑒𝑟𝑟𝑜𝑟
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A model for each protein:
Peptide-based models
22.6464 1.5
17.85773 1.5
15.4947 1.5
14.02125 1.5
18.0965 -1.5
14.59100 -1.5
14.2959 -1.5
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1. Unstable DA 
estimates
2. Unstable
variance
estimates
3. Outliers
Still some issues…
A yeast null protein
Structure of my presentation
• Problem: reliable differential quantitation
• Solution: peptide-based models
• Improving solution via:
1. Shrinkage estimation
2. Borrowing information across proteins
3. Weighing down outliers
• Leads to:
1. Better fold change estimates
2. Better sensitivity and specificity
• Conclusions: all of the above
• Acknowledgements
Problem
1. Unstable DA estimates
2. Unstable variance
estimates
3. Outliers
Solution
1. Shrinkage estimation
2. Borrow information
across proteins
3. Weigh down outlying
peptides
How can we improve upons existing peptide-
based models?
This will lead to:
1. Better fold change estimates
2. Better ranking
1. Shrinkage estimation
E.g. ridge regression: minimize the following loss
function:
 𝑦 − 𝑋  𝛽
2
+ 𝜆𝑡𝑟𝑒𝑎𝑡   𝛽𝑡𝑟𝑒𝑎𝑡
2 + 𝜆𝑝𝑒𝑝   𝛽𝑝𝑒𝑝
2 + 𝜆𝑖𝑛𝑠𝑡𝑟   𝛽𝑖𝑛𝑠𝑡𝑟
2
• Penalty on the effect sizes: shrinkage toward 0
• Biased but (much) more stable estimator
• Sparse data: shrinkage ↗
• 𝜆s: via cross-validation or link with mixed models
2. Borrow information across proteins:
Empirical Bayes variance estimation
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Data decides!
• Stabilizes variance estimates
• Get rid of proteins with low fold changes and low 
variance caused by data sparsity
More details (limma paper):
Smyth (2004), Linear models and empirical bayes methods for assessing differential expression in microarray 
experiments. Stat Appl Genet Mol Biol, 3, Article3.
3. Weigh down outlying peptides
E.g. M estimation with Huber weights
Minimize the following loss function:
 𝒘 𝑦 − 𝑋  𝛽
2
+ 𝜆𝑡𝑟𝑒𝑎𝑡   𝛽𝑡𝑟𝑒𝑎𝑡
2 + 𝜆𝑝𝑒𝑝   𝛽𝑝𝑒𝑝
2 + 𝜆𝑖𝑛𝑠𝑡𝑟   𝛽𝑖𝑛𝑠𝑡𝑟
2
• Weigh down outlying observations
1. Better fold change 
estimates
-> More accurate and
more precise
2. Better specificity and
sensitivity
-> Improved ranking
Results!
1. Better fold change estimates
For null proteins
1. Better fold change estimates
For differentially abundant proteins
2. Better sensitivity and specificity
Conclusions
1. Use peptide-based models
2. Our peptide-based model uses: 
1. Shrinkage estimation
2. Empirical Bayes variance estimation
3. Downweighing of outliers
3. Advantages:
1. More stable fold change estimates
2. Better sensititivity and specificity
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Thank you for your attention!
Questions?
